Showing results (4561-4570 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|April 11, 2020
Impact of Treatment Beyond Progression with Immune Checkpoint Blockade in Hodgkin LymphomaReid W Merryman, Nicole A Carreau, Ranjana H Advani, et al.
The Oncologist|April 17, 2020
The EORTC QLQ-C30 Summary Score as Prognostic Factor for Survival of Patients with Cancer in the "Real-World": Results from the Population-Based PROFILES RegistryOlga Husson, Belle H de Rooij, Jacobien Kieffer, et al.
The Oncologist|April 17, 2020
Opioid Prescribing Trends in Women Following Mastectomy or Breast-Conserving Surgery Before and After the 2014 Federal Reclassification of HydrocodoneDerrick C Gibson, Lin-Na Chou, Mukaila A Raji, et al.
The Oncologist|April 17, 2020
Comprehensive Analysis of AR Alterations in Circulating Tumor DNA from Patients with Advanced Prostate CancerElisa M Ledet, Michael B Lilly, Guru Sonpavde, et al.
The Oncologist|April 17, 2020
Single-Center Experience with Ifosfamide Monotherapy as Second-Line Treatment of Recurrent/Metastatic OsteosarcomaArie Jan Verschoor, Frank M Speetjens, P D Sander Dijkstra, et al.
The Oncologist|August 19, 2016
N-Telopeptide of Type I Collagen Long-Term Dynamics in Breast Cancer Patients With Bone Metastases: Clinical Outcomes and Influence of Extraskeletal MetastasesArlindo R Ferreira, Irina Alho, Ning Shan, et al.
The Oncologist|June 20, 2020
Phase II Study of Low-Dose Afatinib Maintenance Treatment Among Patients with EGFR-Mutated Non-Small Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 1601 (NJLCG1601)Atsushi Nakamura, Hisashi Tanaka, Ryota Saito, et al.
The Oncologist|May 7, 2020
Delta-Like Protein 3 Expression and Targeting in Merkel Cell CarcinomaHao Xie, Frederic J Kaye, Kumiko Isse, et al.
The Oncologist|April 21, 2020
Clinical Practice Observation of Trastuzumab in Patients with Human Epidermal Growth Receptor 2-Positive Metastatic Adenocarcinoma of the Stomach or Gastroesophageal JunctionSalah-Eddin Al-Batran, Enno Moorahrend, Christoph Maintz, et al.
The Oncologist|October 25, 2019
Sorafenib for Patients with Hepatocellular Carcinoma and Child-Pugh B Liver Cirrhosis: Lessons Learned from a Terminated StudyTim A Labeur, Roos Achterbergh, Bart Takkenberg, et al.
Pageof 571